Multiple system atrophy - parkinsonian subtype (msa-P)
Clinical trials for Multiple system atrophy - parkinsonian subtype (msa-P) explained in plain language.
Never miss a new study
Get alerted when new Multiple system atrophy - parkinsonian subtype (msa-P) trials appear
Sign up with your email to follow new studies for Multiple system atrophy - parkinsonian subtype (msa-P), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Spinal zap trial aims to steady blood pressure in Parkinson's patients
Disease control Recruiting nowThis early study tests a spinal cord stimulation therapy called ARC-IM in 5 people with Parkinson's disease or related conditions who experience severe drops in blood pressure when standing (orthostatic hypotension). The main goal is to check safety, and researchers will also mea…
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Sponsor: Ecole Polytechnique Fédérale de Lausanne • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Brain cell transplant trial offers hope for rare Parkinson's-Like disease
Disease control Recruiting nowThis early-stage trial tests a single injection of dopamine-producing cells directly into the brain for people with multiple system atrophy (MSA), a rare and severe movement disorder. The main goal is to check safety and side effects in 9 participants aged 30 to 70. Researchers w…
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Phase 1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New protein therapy hopes to repair brain damage in rare disease
Disease control Recruiting nowThis early-phase trial tests a drug called Aleeto, a nerve repair protein made from stem cells, in 20 people with Multiple System Atrophy (MSA), a rare brain disease. The study checks if Aleeto is safe and might help with symptoms. Participants receive the drug via injection into…
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Early phase 1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:56 UTC
-
DNA hunt for rare brain disease genes begins
Knowledge-focused Recruiting nowThis study collects DNA from up to 1,000 adults with progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple system atrophy (MSA), or related conditions, plus their family members. Researchers will sequence participants' whole genomes to find genetic variants …
Matched conditions: MULTIPLE SYSTEM ATROPHY - PARKINSONIAN SUBTYPE (MSA-P)
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC